Discovery of a RIPK2 Scaffolding Inhibitor for the Treatment of Joint Autoimmune Diseases

被引：0

作者：

Wlodarska, Marta ^{[1
]}

Van Huis, Chad ^{[2
]}

Hoss, Florian ^{[3
]}

Meyer, Rosana ^{[1
]}

Lu, Xiaokang ^{[2
]}

Koelmel, Dominik ^{[2
]}

Sanchez, Brian ^{[2
]}

Lesch, Chuck ^{[2
]}

Telling, Alissa ^{[2
]}

Minns, Martin ^{[1
]}

Mbah, Nneka ^{[2
]}

Lacan, Isabelle ^{[1
]}

Aversa, Robert ^{[1
]}

Lesburg, Charles ^{[1
]}

Yu, Carmen ^{[2
]}

Soisson, Stephen ^{[1
]}

Dales, Natalie ^{[1
]}

Patrick, Darryl ^{[1
]}

Opipari, Anthony ^{[2
]}

Pan, Shifeng ^{[4
]}

Franchi, Luigi ^{[2
]}

机构：

[1] Odyssey Therapeut, Boston, MA USA

[2] Odyssey Therapeut, Ann Arbor, MI USA

[3] Odyssey Therapeut, Frankfurt, Germany

[4] Odyssey Therapeut, San Diego, CA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0061

引用

页码：102 / 103

页数：2

共 50 条

[1] Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease
Lai, Yujun
Wang, Xinhui
Sun, Xue
Wu, Shuwei
Chen, Xin
Yang, Chengkui
Zhang, Wei
Yu, Xiaoliang
Tong, Yushan
Ma, Feng
Zheng, Heng
Zhang, Xiaohu
He, Sudan
BIOCHEMICAL PHARMACOLOGY, 2023, 214
[2] RIPK2 as a promising druggable target for autoimmune diseases
Zhao, Wei
Leng, Rui-Xue
Ye, Dong-Qing
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 118
[3] RIPK2 Scaffolding Inhibitors are a Novel Approach to Block RIPK2 Signaling, a Hallmark of Inflammatory Bowel Disease
Wlodarska, Marta
Mbah, Nneka
Hoss, Florian
Meyer, Rosana
Prochnicki, Tomasz
Lu, Hanbin
McMillan, Elizabeth
VanHuis, Chad
Kolmel, Dominik
Sanchez, Brian
Lu, Xiaokang
Lesch, Chuck
Telling, Alissa
Kenny, Douglas J.
Lacan, Isabelle
Lesburg, Charles A.
Dales, Natalie
Patrick, Darryl
Sokolove, Jeremy
Opipari, Anthony
Franchi, Luigi
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1020 - S1020
[4] Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases
He, Xiaohui
Da Ros, Sara
Nelson, John
Zhu, Xuefeng
Jiang, Tao
Okram, Barun
Jiang, Songchun
Michellys, Pierre-Yves
Iskandar, Maya
Espinola, Sheryll
Jia, Yong
Bursulaya, Badry
Kreusch, Andreas
Gao, Mu-Yun
Spraggon, Glen
Baaten, Janine
Clemmer, Leah
Meeusen, Shelly
Huang, David
Hill, Robert
Van Nguyen-Tran
Fathman, John
Liu, Bo
Tuntland, Tove
Gordon, Perry
Hollenbeck, Thomas
Ng, Kenneth
Shi, Jian
Bordone, Laura
Liu, Hong
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (10): : 1048 - 1053
[5] Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases
Pham, Anh-Tuan
Ghilardi, Amanda Franceschini
Sun, Lijun
FRONTIERS IN PHARMACOLOGY, 2023, 14
[6] Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases
Ma, Duo
Hu, Shuang
Wang, Chun
Ai, Jiaxin
Ma, Jiahai
Gao, Tianwen
Hong, Yaling
Wu, Zhengxing
Gu, Mingzhen
Tang, Xiaoxin
Chang, Yantai
Chen, Qihang
Chen, Shuo
Yu, Qing
Yang, Junjie
Zhang, Chen
Li, Chong
Liu, Xuesong
Shi, Jingbo
Liu, Xinhua
Liu, Yuhai
Liu, Mingming
JOURNAL OF MEDICINAL CHEMISTRY, 2025,
[7] RIPK2: a promising target for cancer treatment
You, Jieqiong
Wang, Ying
Chen, Haifeng
Jin, Fang
FRONTIERS IN PHARMACOLOGY, 2023, 14
[8] RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
Honjo, Hajime
Watanabe, Tomohiro
Kamata, Ken
Minaga, Kosuke
Kudo, Masatoshi
FRONTIERS IN PHARMACOLOGY, 2021, 12
[9] Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
Hrdinka, Matous
Schlicher, Lisa
Dai, Bing
Pinkas, Daniel M.
Bufton, Joshua C.
Picaud, Sarah
Ward, Jennifer A.
Rogers, Catherine
Suebsuwong, Chalada
Nikhar, Sameer
Cuny, Gregory D.
Huber, Kilian V. M.
Filippakopoulos, Panagis
Bullock, Alex N.
Degterev, Alexei
Gyrd-Hansen, Mads
EMBO JOURNAL, 2018, 37 (17):
[10] Discovery of Potent and Selective Receptor-Interacting Serine/ Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)
Yuan, Xue
Chen, Yong
Tang, Minghai
Wei, Yuhan
Shi, Mingsong
Yang, Yingxue
Zhou, Yanting
Yang, Tao
Liu, Jiang
Liu, Kongjun
Deng, Dexin
Zhang, Chufeng
Chen, Lijuan
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (13) : 9312 - 9327

← 1 2 3 4 5 →